share_log

Takeda's HyQvia Receives Expanded Market Authorization From Health Canada

Benzinga ·  Mar 27 13:32

HyQvia is the only up to once monthly (every 2, 3 or 4 weeks) immunoglobulin subcutaneous infusion to treat CIDP in Canada

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 243

Recommended

Write a comment